Tags : Immunology

Top 20 Immunology Companies Based on 2018 Immunology Segment Revenue

The increasing cases of autoimmune disorders such as rheumatoid arthritis are driving the growth of immunology products in the global market. Multiple companies have been focusing on Oncology, Hematology and multiple diseases but due to a drastic increase in the immune disorders, Immunology segment has been widely spared across the globe. In the top 20 […]Read More

Lilly Signs a Global Research and Licensing Agreement with Avidity

Shots: Avidity to receive $20M upfront, $15M equity investment, $405M as development, regulatory & commercial milestones for each target and royalties on sales. Lilly to get WW rights to develop and commercialize the products to be developed in immunology and other indications The companies will develop & commercialize RNA-based therapies with the combination of tissue […]Read More

Shire Announces Acquisition of Sanaplasma AG to Expand its Immunology

Shots: This acquisition is expected to increase continued access for Shire in plasma collection network advancing its facilities of supply and manufacturing units Shire will take over Sanaplasma AG’s 14 plasma centres in the Czech Republic, Hungary with >100 BioLife centres in the US and Austria an addition to its EU plasma collection unit The […]Read More